However, as the tumour progressed, the percentage and number of NK cells and CD8+T cells in Kras-mutated mice had an obvious decrease compared to WT mice in stage 3 tumours (Figures 2(d)–2(f)). This evidence concerns the gene KRAS and neoplasm.